What did @strivewithtrae actually say?
Honestly, there is not much to work with here. The transcript is a single repeated phrase, "I'm just gonna wait, I'm just gonna wait, I'm just gonna wait," which appears to be audio synced to a trending sound rather than a direct medical claim. The caption does the heavier lifting, with the creator stating they are "still showing up everyday" and "finally feeling confident" in their body, framed within GLP-1 content.
So what we are actually fact-checking is the implied narrative: that GLP-1 receptor agonist use correlates with improved body confidence and consistent daily habits. That is a real and researchable claim, even if it arrived wrapped in a TikTok audio trend rather than a spoken statement.
Does the science back this up?
Surprisingly, yes, at least in part. The link between GLP-1 therapy and improved psychological outcomes, including body image and self-reported confidence, is real and documented. It is not just about the number on the scale.
A 2023 study by Wharton et al. in Obesity found that patients on semaglutide reported statistically significant improvements in health-related quality of life, including physical functioning and self-esteem measures, compared to placebo. Separately, Rubino et al. (2021, NEJM) noted in the STEP 4 trial that sustained weight loss with semaglutide was associated with continued improvements in patient-reported outcomes. The "showing up every day" framing also touches on something real: adherence to GLP-1 therapy is closely tied to behavioral engagement. Patients who maintain consistent habits alongside medication tend to see better long-term results, per Wilding et al. (2021, NEJM, STEP 1 trial).
What did they get wrong (or right)?
They did not really get anything wrong because they did not say much. The caption sentiment is broadly consistent with what patients report and what trials have measured. Credit where it is due: framing GLP-1 use as a complement to daily effort rather than a replacement for it is the right message. Too much GLP-1 content on TikTok positions these medications as passive fixes. This post, at least in tone, does not do that.
The concern is what is absent. No mention of the fact that body confidence improvements can plateau or reverse if medication is stopped. Wilding et al. (2022, Diabetes, Obesity and Metabolism) showed that one year after semaglutide discontinuation, patients regained an average of two-thirds of their lost weight, and psychological benefits tracked similarly. A post that celebrates confidence without acknowledging that this outcome requires ongoing commitment, medical supervision, and sometimes lifelong treatment is incomplete, even if it is not wrong.
What should you actually know?
GLP-1 receptor agonists like semaglutide and tirzepatide do produce real, measurable improvements in how patients feel about their bodies, and that is not nothing. But a few things deserve plain language.
- Body image improvements are real but not universal. Trial data shows averages, and individual responses vary significantly based on starting weight, comorbidities, and psychological history.
- "Feeling confident" is a patient-reported outcome, not a clinical endpoint. It matters, but it is harder to measure than A1C or BMI.
- Stopping GLP-1 therapy frequently reverses both physical and psychological gains. This is a long-term treatment for most patients, not a short course.
- Compounded versions of semaglutide or tirzepatide are not equivalent to FDA-approved brand-name medications. Do not assume they perform identically.
- If you are considering GLP-1 therapy based on social media content, that is a reasonable starting point for curiosity, but a licensed clinician should be the one making the actual prescribing decision based on your specific health profile.
The bottom line
This video is low on claims and high on vibes, which makes it hard to fact-check in a traditional sense. The implied message, that GLP-1 therapy can support body confidence while you continue showing up daily, is broadly accurate. The gap is context. Social media posts that celebrate wins without explaining the conditions required to sustain them are not misinformation exactly, but they are incomplete. Patients deserve both the good news and the full picture.